Participation of Signaling Cascades in the Regulation of Erythropoiesis under Conditions of Cytostatic Treatment
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605537984 | ||
| 003 | CHVBK | ||
| 005 | 20210128100900.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150101xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2747-6 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2747-6 | ||
| 245 | 0 | 0 | |a Participation of Signaling Cascades in the Regulation of Erythropoiesis under Conditions of Cytostatic Treatment |h [Elektronische Daten] |c [A. Dygai, V. Zhdanov, L. Miroshnichenko, E. Udut, G. Zyuz'kov, E. Simanina, A. Chaikovskii, L. Stavrova, E. Trofimova, Ya. Burmina] |
| 520 | 3 | |a We studied the role of signaling pathways in the regulation of erythropoiesis against the background of myelosuppression caused by administration of 5-fluorouracil. The important role of cyclic AMP in the maturation of erythroid progenitors after cytostatic treatment was demonstrated. The secretory activity of myelokaryocytes during the period of erythroid hemopoiesis recovery is mainly regulated via the p38 MAPK signaling pathway; non-erythropoietin factors are involved in the formation of erythropoietic activity of adherent cells of the microenvironment. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a NF-κB |2 nationallicence | |
| 690 | 7 | |a protein kinase p38 |2 nationallicence | |
| 690 | 7 | |a adenylatecyclase |2 nationallicence | |
| 690 | 7 | |a myelosuppression |2 nationallicence | |
| 690 | 7 | |a erythropoietin |2 nationallicence | |
| 700 | 1 | |a Dygai |D A. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Zhdanov |D V. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Miroshnichenko |D L. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Udut |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Zyuz'kov |D G. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Simanina |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Chaikovskii |D A. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Stavrova |D L. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Trofimova |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 700 | 1 | |a Burmina |D Ya |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/3(2015-01-01), 304-307 |x 0007-4888 |q 158:3<304 |1 2015 |2 158 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2747-6 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2747-6 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Dygai |D A. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Zhdanov |D V. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Miroshnichenko |D L. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Udut |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Zyuz'kov |D G. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Simanina |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Chaikovskii |D A. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Stavrova |D L. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Trofimova |D E. |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Burmina |D Ya |u E. D. Goldberg Research Institute of Pharmacology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/3(2015-01-01), 304-307 |x 0007-4888 |q 158:3<304 |1 2015 |2 158 |o 10517 | ||